Characterization of a calcium-regulation domain of the skeletal-muscle ryanodine receptor

Biochem J. 2000 Oct 1;351(Pt 1):57-65. doi: 10.1042/0264-6021:3510057.

Abstract

A negatively charged region of the N-terminal portion of the skeletal ryanodine receptor (RyR), located between residues 1872-1923, is involved in Ca (2+)-dependent regulation of the Ca(2+)-release channel. This region is divergent between the skeletal (RyR1) and cardiac (RyR2) isoforms of the channel, and is known as D3. Ca(2+) exerts important regulatory functions on the RyR, being involved in both activation and inactivation functions of the channel, i.e. the effects occurring at micromolar and millimolar Ca(2+) concentrations respectively. To characterize the role of D3 in the Ca(2+)-dependent regulation of the Ca(2+)-release channel, we studied the functional consequences of deleting the D3 region from RyR1 (DeltaD3-RyR1) using a heterologous expression system, [(3)H]ryanodine binding assays and single-channel recordings in lipid bilayers. Deletion of the D3 region selectively affected Ca(2+)-dependent regulation of RyR1, but did not alter [(3)H]ryanodine binding or the effect of other modulators on the RyR. Compared with full-length RyR1 (wt-RyR1), the Ca(2+)-dependence curve of DeltaD3-RyR1 is broader, reflecting increased sensitivity to Ca(2+) activation and decreased sensitivity to Ca(2+) inactivation. In addition, DeltaD3-RyR1 was more resistant to inhibition by Mg(2+). Comparison of the effect of caffeine on wt-RyR1 and DeltaD3-RyR1 suggested that D3 is an important region of RyR that participates in Ca(2+)-dependent activation and inactivation of the Ca(2+)-release channel.

MeSH terms

  • Animals
  • CHO Cells
  • Caffeine / pharmacology
  • Calcium / metabolism
  • Calcium / pharmacology*
  • Calcium Channels / metabolism
  • Cricetinae
  • Ion Channel Gating / drug effects
  • Lipid Bilayers / metabolism
  • Magnesium / pharmacology
  • Membrane Potentials / drug effects
  • Muscle, Skeletal / metabolism*
  • Protein Binding / drug effects
  • Protein Structure, Tertiary
  • Ryanodine / metabolism
  • Ryanodine Receptor Calcium Release Channel / chemistry*
  • Ryanodine Receptor Calcium Release Channel / genetics
  • Ryanodine Receptor Calcium Release Channel / metabolism*
  • Sequence Deletion / genetics

Substances

  • Calcium Channels
  • Lipid Bilayers
  • Ryanodine Receptor Calcium Release Channel
  • Ryanodine
  • Caffeine
  • Magnesium
  • Calcium